Accessed from 10.6.1.

1 by merck1 on Mon May 11 20:23:49 EDT 2015

Front Matter xxxii Donors / People USP 38

2013 Recognition of
Monograph and Reference
Material Donors
USP acknowledges and appreciates the support of the fol- Farmak, AS
lowing companies that participated in the USP standards- Ferring Pharmaceuticals, Inc.
setting process by providing information for the develop- Formosa Laboratories, Inc.
ment of new monographs or by donating reference stan- Fresenius Kabi Oncology, Ltd.
dard candidate materials. The companies listed are those Fuji Chemical Industry Company, Ltd.
that either provided monographs that were published as Ganeden Biotech, Inc.
proposals in 2013 or donated reference material candidates Gattefosse Corporation SAS
that were released as USP Reference Standards in 2013. GE Healthcare, Inc.
3V Inc. Gland Pharma, Ltd.
Abbvie GlaxoSmithKline
ACS Dobfar Glenmark Generics, Ltd.
Actavis Gnosis, S.p.A.
Ajinomoto Aminoscience, LLC Harman Finochem, Ltd.
Aker BioMarine AS Hayashibara Company, Ltd.
Alcon Laboratories Hetero Drugs, Ltd.
Alkaloids Corporation Havione Farmaciencia, S.A.
Almirall S.A. ICL Performance Products
American Laboratories, Inc. Icrom, S.p.A.
American Sugar Refining, Inc. International Vitamin Corporation
Amersham Biosciences Ipca Laboratories, Ltd.
Amgen, Inc. Jiangsu Hengrui Medicine Company
Angelini Johnson & Johnson
Apicore, LLC Johnson Matthey Pharmaceuticals, Inc.
Apotex, Inc. JRS Pharma LP
Astellas Pharmaceuticals, Inc. Jubilant Life Sciences
AstraZeneca Pharmaceuticals, Inc. KAH Specialty Products, LLC
Aurobindo Pharma, Ltd. Kongo Chemical Company, Ltd.
Axellia Pharmaceuticals, Inc. Kremers Urban Pharmaceuticals, Inc.
BASF Corporation Lancaster Laboratories, Inc.
Baxter Healthcare Lanxess Corporation
Bayer Corporation Leo Pharma A/S
Bioriginal Food & Science Corporation Lipoid KG
Bloomage Freda Biopharm Company Lonza Group AG
Boehringer Ingelheim Lundbeck, Inc.
Bristol-Myers Squibb Lupin Pharmaceuticals, Inc.
Cambrex Profarmaco Milano S.r.l. Macfarlan Smith, Ltd.
Cargill, Inc. Medichem S.A.
CellGenix, GmbH Medicis Pharmaceutical Corporation
Chevron Phillips Chemical Merck & Co., Inc.
Chifeng Pharmaceutical Co., Ltd. Microlabs, Ltd.
Chrysantis, Inc. Minsheng Group Shaoxing Pharma Company, Ltd.
Cipla, Ltd. Mylan Pharmaceuticals, Inc.
Citrique Belge SA Natural Remedies, Pvt. Ltd.
CordenPharma Naturex, Inc.
Covidien/Mallinckrodt Neptune Technologies & Bioressources, Inc.
Croda, Inc. Neuland Laboratories, Ltd.
Cyanotech Corporation Novartis Pharmaceuticals Corporation
Daiichi Sankyo Co., Ltd. Novozymes Delta, Ltd.
Dionex Corporation Nusil Technology, LLC
Divis Laboratories, Ltd. Nutrition 21
Dow Chemical Company Opocrin, S.p.A.
Dr. Reddys Laboratories Ltd. Patheon, Inc.
DSM Nutritional Products, Inc. Perrigo
DuPont Pfizer
Eli Lilly and Company Pharmacosmos A/S
Erregierre, S.P.A. Piramal Healthcare
Evonik Industries Polygal AG
Excella GmbH POM Wonderful, LLC
Fabbrica Italiana Sintetici Procos, S.p.A.

Official from May 1, 2015

Copyright (c) 2015 The United States Pharmacopeial Convention. All rights reserved.
Accessed from 10.6.1.1 by merck1 on Mon May 11 20:23:49 EDT 2015

USP 38 People / Donors xxxiii

Front Matter
Quimica Sintetica S.A. Symed Labs, Ltd.
Ranbaxy Pharmaceuticals, Inc. Symrise GMBH & Company, KG
Reliance Life Sciences Takeda Pharmaceutical Co., Ltd.
Roche Diagnostics, GmbH Teva Pharmaceutical Industries, Inc.
RPG Life Sciences, Ltd. Tianjin Tianfa Pharmaceuticals
Safe Foods Corporation TSI Health Sciences, Inc.
SAI Advantium Pharma, Ltd. Valeant Pharmaceuticals International, Inc.
Sandoz, Inc. Virchow Group
Sanofi-Aventis Welch, Holme & Clark, Co., Inc.
ScinoPharm Taiwan, Ltd. Wellesley Therapeutics, Inc.
Septodont Wilshire Technologies, Inc.
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Wockhardt, Ltd.
Shanghai Institute of Materia Medica Chinese Academy Wuhan Wuyao Pharmaceutical Company, Inc.
of Sciences Wuxi Howfond Biopharma Company, Ltd.
Shasun Pharmaceuticals, Ltd. Yunnan Hande BioTech Company, Ltd.
Sicor S.r.l. Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
Sifavitor S.r.l. Zhejiang Conba Drug Discovery and Development Com-
Sterling S.N.I.F.F. Italia, S.p.A. pany, Ltd.
Strides Arcolab, Ltd. Zhejiang Hangzhou Xinfu Pharmaceutical Company, Ltd.
Sun Pharmaceutical, Ltd. Zhejiang Huahai Pharmaceutical Company, Ltd.
Suven Life Sciences, Ltd. Zydus Cadila Healthcare, Ltd.
Suzhou Pharmaceutical Group, Co., Ltd.

Official from May 1, 2015

Copyright (c) 2015 The United States Pharmacopeial Convention. All rights reserved.
 Accessed from 10.6.1.1 by merck1 on Mon May 11 20:23:49 EDT 2015
Front Matter xxxiv Articles of Incorporation USP 38

Articles of Incorporation
In May of 1900, the USP Board of Trustees was directed filing was slightly delayed in order to appoint appropriate
by the Convention to incorporate the USP organization representatives. Nevertheless, the articles of incorporation
under the laws of the District of Columbia. Because the Dis- were prepared, appropriately signed, and finally filed on July
trict of Columbia required that the majority of officers sub- 11 of that year. The original certificate reads as follows:
scribing to the Certificate of Incorporation be residents, the

Certification of Incorporation
This is to certify that we, whose names are hereunto subscribed, citizens of the United States, of full age, and a majority
citizens of the District of Columbia, do associate ourselves together pursuant to the provisions of sections 545552 inclusive
of the Revised Statutes of the United States relating to the District of Columbia and of the Act of Congress to amend the
same, approved the twenty-third day of April 1884, under the corporate name of The United States Pharmacopoeial Conven-
tion.
This Association is organized for a period of nine hundred and ninety-nine years. The particular objects and business of
this Association are the encouragement and promotion of the science and art of medicine and pharmacy by selecting by
research and experiment and other proper methods and by naming such materials as may be properly used as medicines
and drugs with formulas for their preparation; by establishing one uniform standard and guide for the use of those engaged
in the practice of medicine and pharmacy in the United States whereby the identity, strength, and purity of all such
medicines and drugs may be accurately determined, and for other like and similar purposes; and by printing and distributing
at suitable intervals such formulas and the results of such and similar selections, names and determinations among the
members of this Association, pharmacists, and physicians generally in the United States and others interested in pharmacy
and medicine.
The management and control of the affairs, funds, and property of this Association for the first year of its existence shall
be vested in a Board of Trustees consisting of the seven following persons:

ALBERT E. EBERT GEORGE W. SLOAN

SAMUEL A.D. SHEPPARD HORATIO C. WOOD
WILLIAM S. THOMPSON CHARLES RICE
CHARLES E. DOHME

In testimony whereof we have hereunto set our hands and affixed our seals this seventh day of July, 1900.
WILLIAM S. THOMPSON [SEAL] WILLIAM M. MEW [SEAL]
G. LLOYD MAGRUDER [SEAL] FRANK M. CRISWELL [SEAL]
JOHN T. WINTER [SEAL] MURRAY G. MOTTER [SEAL]
THOMAS C. SMITH [SEAL]

Official from May 1, 2015

Copyright (c) 2015 The United States Pharmacopeial Convention. All rights reserved.